{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T06:46:10Z","timestamp":1792392370048,"version":"4.4.0"},"reference-count":154,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004252","name":"Qatar University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004252","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2027,3]]},"DOI":"10.1016\/j.cca.2026.122900","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T09:03:21Z","timestamp":1792227801000},"page":"122900","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Type 1 diabetes metabolomics and multi-omics: Current applications, limitations, and future directions - A narrative review"],"prefix":"10.1016","volume":"594","author":[{"given":"Husam Eldin Elhag","family":"Abugabr Elhag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haya","family":"Al-Sulaiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2026.122900_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/20420188251337988","article-title":"Multi-omics investigation of prospective therapeutic targets for type 1 diabetes","volume":"16","author":"Zhang","year":"2025","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2026.122900_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-024-70660-8","article-title":"Nutritional status and extended metabolic screening in Egyptian children with uncomplicated type 1 diabetes","volume":"14","author":"Sakhr","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2026.122900_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2026.121137","article-title":"Novel biomarkers of diabetic kidney disease in type 1 diabetes","author":"Przezak","year":"2026","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2026.122900_bb0020","author":"WHO"},{"key":"10.1016\/j.cca.2026.122900_bb0025","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"402","author":"Ong","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2026.122900_bb0030","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S2213-8587(25)00299-2","article-title":"11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050","volume":"14","author":"Genitsaridi","year":"2026","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.cca.2026.122900_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2024.119825","article-title":"MTHFR gene polymorphisms in diabetes mellitus","volume":"561","author":"Cai","year":"2024","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2026.122900_bb0040","doi-asserted-by":"crossref","first-page":"112277","DOI":"10.1016\/j.diabres.2025.112277","article-title":"Global type 1 diabetes prevalence, incidence, and mortality estimates 2025: Results from the International diabetes Federation Atlas, 11th Edition, and the T1D Index Version 3.0","volume":"225","author":"Ogle","year":"2025","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.cca.2026.122900_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2024.111963","article-title":"Comparing ADA and IDF diagnostic criteria for intermediate hyperglycaemia and diabetes in the SHiDS study","volume":"219","author":"Zhang","year":"2025","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.cca.2026.122900_bb0050","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.70167","article-title":"Intersecting molecular pathways in cardiovascular disease and diabetes mellitus: emerging roles of inflammation and therapeutics","volume":"42","author":"Anagnostopoulou","year":"2026","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.cca.2026.122900_bb0055","article-title":"GADA as a biomarker for type 1 diabetes","author":"Rekha","year":"2025","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2026.122900_bb0060","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/dom.16354","article-title":"Type 1 diabetes risk factors, risk prediction and presymptomatic detection: evidence and guidance for screening","volume":"27","author":"Bonifacio","year":"2025","journal-title":"Diabetes. Obes. Metab."},{"key":"10.1016\/j.cca.2026.122900_bb0065","first-page":"1","article-title":"The management of type 1 diabetes in adults. The updated 2026 consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","author":"Holt","year":"2026","journal-title":"Diabetologia"},{"key":"10.1016\/j.cca.2026.122900_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106792","article-title":"Lessons and gaps in the prediction and prevention of type 1 diabetes","volume":"193","author":"Mameli","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.cca.2026.122900_bb0075","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1007\/s00125-025-06437-z","article-title":"Immune cell\u2013adipose tissue crosstalk in metabolic diseases with a focus on type 1 diabetes","volume":"68","author":"Alzaid","year":"2025","journal-title":"Diabetologia"},{"key":"10.1016\/j.cca.2026.122900_bb0080","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/jdi.13911","article-title":"Characteristic changes in plasma glutamate levels and free amino acid profiles in Japanese patients with type 1 diabetes mellitus","volume":"14","author":"Kawamori","year":"2023","journal-title":"J. Diabetes Investig."},{"key":"10.1016\/j.cca.2026.122900_bb0085","doi-asserted-by":"crossref","first-page":"357","DOI":"10.33546\/bnj.3701","article-title":"Factors influencing quality of life in adolescents with type 1 diabetes mellitus: A cross-sectional study in South Korea","volume":"11","author":"Park","year":"2025","journal-title":"Belitung Nurs. J."},{"key":"10.1016\/j.cca.2026.122900_bb0090","doi-asserted-by":"crossref","first-page":"1539116","DOI":"10.3389\/fped.2025.1539116","article-title":"Bibliometric analysis of health-related quality of life in adolescents with type 1 diabetes","volume":"13","author":"Mart\u00edn-\u00c1vila","year":"2025","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.cca.2026.122900_bb0095","doi-asserted-by":"crossref","first-page":"1211015","DOI":"10.3389\/fendo.2023.1211015","article-title":"Circulating metabolic signatures of rapid and slow progression to type 1 diabetes in islet autoantibody-positive children","volume":"14","author":"Lamichhane","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.cca.2026.122900_bb0100","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fendo.2020.00078","article-title":"The role of gut microbiota and environmental factors in type 1 diabetes pathogenesis","volume":"11","author":"Dedrick","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.cca.2026.122900_bb0105","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41577-023-00985-4","article-title":"The immunology of type 1 diabetes","volume":"24","author":"Herold","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cca.2026.122900_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2024.101998","article-title":"Decoding the immune dance: Unraveling the interplay between beta cells and type 1 diabetes","volume":"88","author":"Roy","year":"2024","journal-title":"Mol. Metab."},{"key":"10.1016\/j.cca.2026.122900_bb0115","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/joim.13648","article-title":"Possible heterogeneity of initial pancreatic islet beta-cell autoimmunity heralding type 1 diabetes","volume":"294","author":"Lernmark","year":"2023","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.cca.2026.122900_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.deman.2024.100246","article-title":"Autoantibodies in type 1 diabetes: Prevalence and clinical profiles","volume":"17","author":"Hazime","year":"2025","journal-title":"Diabetes Epidemiol. Manag."},{"key":"10.1016\/j.cca.2026.122900_bb0125","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1038\/s41467-022-31227-1","article-title":"Islet autoantibody seroconversion in type-1 diabetes is associated with metagenome-assembled genomes in infant gut microbiomes","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cca.2026.122900_bb0130","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.clnesp.2023.06.005","article-title":"Plasma amino acid signatures define types of pediatric diabetes","volume":"57","author":"Tosur","year":"2023","journal-title":"Clin. Nutr. ESPEN"},{"key":"10.1016\/j.cca.2026.122900_bb0135","first-page":"1276","article-title":"Consensus guidance for monitoring individuals with islet autoantibody\u2013positive pre-stage 3 type 1 diabetes","volume":"47","author":"Phillip","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cca.2026.122900_bb0140","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s10020-024-01046-9","article-title":"Metabolomic signature of pediatric diabetic ketoacidosis: key metabolites, pathways, and panels linked to clinical variables","volume":"30","author":"Spagnolo","year":"2024","journal-title":"Mol. Med."},{"key":"10.1016\/j.cca.2026.122900_bb0145","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.448","article-title":"Catabolism of fats and branched-chain amino acids in children with Type 1 diabetes: Association with glycaemic control and total daily insulin dose","volume":"6","author":"Hendrix","year":"2023","journal-title":"Endocrinol. Diabetes Metab."},{"key":"10.1016\/j.cca.2026.122900_bb0150","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.5747","article-title":"Profile of plasma free amino acids, carnitine and acylcarnitines, and JAK2v617f mutation as potential metabolic markers in children with type 1 diabetic nephropathy","volume":"37","author":"Hassan","year":"2023","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.cca.2026.122900_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2023.117298","article-title":"N-glycosylation of serum proteins in adult type 1 diabetes mellitus exposes further changes compared to children at the disease onset","volume":"543","author":"Nem\u010di\u0107","year":"2023","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2026.122900_bb0160","doi-asserted-by":"crossref","first-page":"6003102","DOI":"10.1155\/2023\/6003102","article-title":"Metabolomics and lipidomics studies in pediatric type 1 diabetes: biomarker discovery for the early diagnosis and prognosis","volume":"2023","author":"Liu","year":"2023","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.cca.2026.122900_bb0165","article-title":"Machine learning models for early prediction of type 1 diabetes: a systematic review","volume":"18","author":"Saad Aldeen","year":"2026","journal-title":"Cureus"},{"key":"10.1016\/j.cca.2026.122900_bb0170","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.cca.2022.12.019","article-title":"Serum metabolomics identified metabolite biomarkers and distinguished maturity-onset diabetes of the young from type 1 diabetes in the Chinese population","volume":"539","author":"Liu","year":"2023","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2026.122900_bb0175","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.2147\/DMSO.S370158","article-title":"Application of metabolomics in various types of diabetes","volume":"15","author":"Wu","year":"2022","journal-title":"Diabetes Metab. Syndr. Obes. Targets Ther."},{"key":"10.1016\/j.cca.2026.122900_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e36006","article-title":"MODY calculator applied in patients with clinical diagnosis of type 1 diabetes mellitus: Is a higher cutoff needed?","volume":"10","author":"Peghinelli","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.cca.2026.122900_bb0185","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1124\/pharmrev.121.000408","article-title":"Acylcarnitines: nomenclature, biomarkers, therapeutic potential, drug targets, and clinical trials","volume":"74","author":"Dambrova","year":"2022","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.cca.2026.122900_bb0190","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1038\/s41598-024-55032-6","article-title":"Metabolomic associations of impaired awareness of Hypoglycaemia in type 1 diabetes","volume":"14","author":"Varkevisser","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2026.122900_bb0195","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.2147\/DMSO.S357007","article-title":"A contemporary insight of metabolomics approach for type 1 diabetes: potential for novel diagnostic targets","volume":"519","author":"Chai","year":"2022","journal-title":"Diabetes Metab. Syndr. Obes. Targets Ther."},{"key":"10.1016\/j.cca.2026.122900_bb0220","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1007\/s00125-019-04980-0","article-title":"Circulating metabolites in progression to islet autoimmunity and type 1 diabetes","volume":"62","author":"Lamichhane","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.cca.2026.122900_bb0225","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13098-024-01257-4","article-title":"Metabolomics analysis of serum and urine in type 1 diabetes patients with different time in range derived from continuous glucose monitoring","volume":"16","author":"Ma","year":"2024","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.cca.2026.122900_bb0230","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1007\/s40618-026-02973-6","article-title":"Metabolomic signatures of glycemic control in type 1 diabetes: insights from continuous glucose monitoring","volume":"49","author":"de Lope Qui\u00f1ones","year":"2026","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.cca.2026.122900_bb0235","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000042755","article-title":"Association of the lipidome with type 1 diabetes and the mediated effect of metabolites: A Mendelian randomization study","volume":"104","author":"Yin","year":"2025","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cca.2026.122900_bb0240","doi-asserted-by":"crossref","DOI":"10.1186\/s12953-025-00241-8","article-title":"Mass-spectrometry based metabolomics: an overview of workflows, strategies, data analysis and applications","volume":"23","author":"Hajnajafi","year":"2025","journal-title":"Proteome Sci."},{"key":"10.1016\/j.cca.2026.122900_bb0245","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12014-023-09429-6","article-title":"Systematic review of type 1 diabetes biomarkers reveals regulation in circulating proteins related to complement, lipid metabolism, and immune response","volume":"20","author":"Sarkar","year":"2023","journal-title":"Clin. Proteomics"},{"key":"10.1016\/j.cca.2026.122900_bb0250","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13099-025-00779-0","article-title":"Distinct gut microbiota signatures and metabolic dysregulation in individuals with type 1 diabetes: insights into a microbiome-metabolite axis","volume":"17","author":"Haque","year":"2025","journal-title":"Gut Pathog."},{"key":"10.1016\/j.cca.2026.122900_bb0255","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40168-021-01193-9","article-title":"Metabolite-based dietary supplementation in human type 1 diabetes is associated with microbiota and immune modulation","volume":"10","author":"Bell","year":"2022","journal-title":"Microbiome"},{"key":"10.1016\/j.cca.2026.122900_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e10073","article-title":"Corresponding risk factors between cognitive impairment and type 1 diabetes mellitus: A narrative review","volume":"8","author":"Jin","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.cca.2026.122900_bb0200","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11306-020-01666-2","article-title":"The key points in the pre-analytical procedures of blood and urine samples in metabolomics studies","volume":"16","author":"Bi","year":"2020","journal-title":"Metabolomics"},{"key":"10.1016\/j.cca.2026.122900_bb0205","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3390\/metabo10060229","article-title":"Recommendations and best practices for standardizing the pre-analytical processing of blood and urine samples in metabolomics","volume":"10","author":"Gonz\u00e1lez-Dom\u00ednguez","year":"2020","journal-title":"Metabolites"},{"key":"10.1016\/j.cca.2026.122900_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.682134","article-title":"A comparison of serum and plasma blood collection tubes for the integration of epidemiological and metabolomics data","volume":"8","author":"Sotelo-Orozco","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.cca.2026.122900_bb0215","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/jop.70097","article-title":"Combined analysis of salivary metabolomics and microbiota in type 1 diabetics with xerostomia: a pilot study","volume":"55","author":"Gao","year":"2025","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.cca.2026.122900_bb0265","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3390\/metabo11090587","article-title":"Salivary metabolomics for diagnosis and monitoring diseases: challenges and possibilities","volume":"11","author":"Hyv\u00e4rinen","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.cca.2026.122900_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.115145","article-title":"Evaluation of critical factors in the preparation of saliva sample from healthy subjects for metabolomics","volume":"223","author":"Nam","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.cca.2026.122900_bb0275","doi-asserted-by":"crossref","first-page":"1624878","DOI":"10.3389\/fendo.2025.1624878","article-title":"Metabolomics uncovers the diabetes metabolic network: from pathophysiological mechanisms to clinical applications","volume":"16","author":"Xu","year":"2025","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.cca.2026.122900_bb0280","doi-asserted-by":"crossref","first-page":"1588718","DOI":"10.3389\/fendo.2025.1588718","article-title":"LC-MS-based conventional metabolomics combined with machine learning models to identify metabolic markers for the diagnosis of type I diabetes","volume":"16","author":"Tuerxunyiming","year":"2025","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.cca.2026.122900_bb0285","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1021\/acs.jproteome.5c00301","article-title":"Visualization of early and late molecular events associated with the development of type 1 diabetes using nmr spectroscopy","volume":"24","author":"Sahoo","year":"2025","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.cca.2026.122900_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2025.112380","article-title":"The potential of 1H NMR spectroscopy for diabetes diagnosis: a review of current applications and future directions","volume":"226","author":"Schiavenin","year":"2025","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.cca.2026.122900_bb0295","doi-asserted-by":"crossref","first-page":"RP98709","DOI":"10.7554\/eLife.98709.3","article-title":"Nuclear magnetic resonance-based metabolomics with machine learning for predicting progression from prediabetes to diabetes","volume":"13","author":"Li","year":"2024","journal-title":"Elife"},{"key":"10.1016\/j.cca.2026.122900_bb0300","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jmsacl.2022.06.003","article-title":"Multiplexed quantification of insulin and C-peptide by LC-MS\/MS without the use of antibodies","volume":"25","author":"Foulon","year":"2022","journal-title":"J. Mass Spectrom. Adv. Clin. Lab"},{"key":"10.1016\/j.cca.2026.122900_bb0305","doi-asserted-by":"crossref","DOI":"10.1002\/ansa.202400007","article-title":"Challenges and recent advances in quantitative mass spectrometry-based metabolomics","volume":"5","author":"Ghafari","year":"2024","journal-title":"Anal. Sci. Adv."},{"key":"10.1016\/j.cca.2026.122900_bb0310","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.3390\/molecules29112530","article-title":"Advanced mass spectrometry-based biomarker identification for metabolomics of diabetes mellitus and its complications","volume":"29","author":"Zhang","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.cca.2026.122900_bb0345","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s13300-023-01372-x","article-title":"Nuclear magnetic resonance-based lipidomics in the assessment of cardiometabolic risk in type 1 diabetes: an exploratory analysis","volume":"14","author":"Ser\u00e9s-Noriega","year":"2023","journal-title":"Diabetes Ther."},{"key":"10.1016\/j.cca.2026.122900_bb0350","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s00125-021-05584-3","article-title":"Urinary metabolite profiling and risk of progression of diabetic nephropathy in 2670 individuals with type 1 diabetes","volume":"65","author":"Mutter","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/j.cca.2026.122900_bb0355","doi-asserted-by":"crossref","first-page":"1107162","DOI":"10.3389\/fendo.2023.1107162","article-title":"Systematic assessment of streptozotocin-induced diabetic metabolic alterations in rats using metabolomics","volume":"14","author":"Si","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.cca.2026.122900_bb0360","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202502006","article-title":"Targeted and untargeted GC\u2013MS metabolomics coupled with multivariate chemometric modeling reveals pioglitazone\u2019s impact on diabetic rats","volume":"22","author":"Abduljabbar","year":"2025","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.cca.2026.122900_bb0365","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3390\/microorganisms12050931","article-title":"Innovative biomarkers for obesity and type 1 diabetes based on bifidobacterium and metabolomic profiling","volume":"12","author":"Nobili","year":"2024","journal-title":"Microorganisms"},{"key":"10.1016\/j.cca.2026.122900_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2023.110578","article-title":"Circulating metabolomic and lipidomic changes in subjects with new-onset type 1 diabetes after optimization of glycemic control","volume":"197","author":"Julve","year":"2023","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.cca.2026.122900_bb0375","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3390\/biomedicines10051189","article-title":"Lipidomics analysis of free fatty acids in human plasma of healthy and diabetic subjects by liquid chromatography-high resolution mass spectrometry (LC-HRMS)","volume":"10","author":"Kokotou","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.cca.2026.122900_bb0380","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1007\/s00125-023-05989-2","article-title":"Metabolomic insights into maternal and neonatal complications in pregnancies affected by type 1 diabetes","volume":"66","author":"Meek","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/j.cca.2026.122900_bb0385","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3390\/nu15030518","article-title":"Serum metabolomics reveals a potential benefit of methionine in type 1 diabetes patients with poor glycemic control and high glycemic variability","volume":"15","author":"Zhang","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.cca.2026.122900_bb0390","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1177\/0003702821990357","article-title":"Raman spectroscopy for adipose tissue assessment in rat models of obesity and type 1 diabetes","volume":"75","author":"Donju\u00e1n-Loredo","year":"2021","journal-title":"Appl. Spectrosc."},{"key":"10.1016\/j.cca.2026.122900_bb0395","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.molmed.2024.07.009","article-title":"Exploring new frontiers in type 1 diabetes through advanced mass-spectrometry-based molecular measurements","volume":"30","author":"Sarkar","year":"2024","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.cca.2026.122900_bb0400","doi-asserted-by":"crossref","first-page":"6657","DOI":"10.1007\/s00216-022-04229-7","article-title":"Spatial localization of \u03b2-unsaturated aldehyde markers in murine diabetic kidney tissue by mass spectrometry imaging","volume":"414","author":"Harkin","year":"2022","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.cca.2026.122900_bb0405","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.3390\/ijerph18052263","article-title":"MALDI-TOF protein profiling reflects changes in type 1 diabetes patients depending on the increased amount of adipose tissue, poor control of diabetes and the presence of chronic complications","volume":"18","author":"Zawada","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.cca.2026.122900_bb0315","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11892-022-01449-0","article-title":"Metabolomics of type 1 and type 2 diabetes: insights into risk prediction and mechanisms","volume":"22","author":"Izundegui","year":"2022","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.cca.2026.122900_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107101","article-title":"Selected new approaches and future perspectives in liquid chromatography for the analysis of emerging modalities","volume":"209","author":"Fekete","year":"2025","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.cca.2026.122900_bb0325","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1016\/j.apsb.2021.05.013","article-title":"Spatial-resolved metabolomics reveals tissue-specific metabolic reprogramming in diabetic nephropathy by using mass spectrometry imaging","volume":"11","author":"Wang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.cca.2026.122900_bb0330","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1038\/nutd.2013.33","article-title":"Children who develop type 1 diabetes early in life show low levels of carnitine and amino acids at birth: does this finding shed light on the etiopathogenesis of the disease?","volume":"3","author":"La Marca","year":"2013","journal-title":"Nutr. Diabetes"},{"key":"10.1016\/j.cca.2026.122900_bb0335","doi-asserted-by":"crossref","unstructured":"L.A. Nierves, T.T. Lin, A. Moradian, Q. Shen, S. Sechi, M.J. MacCoss, J. Qu, J.E. van Eyk, A.N. Hoofnagle, W.-J. Qian, Biomarkers, Proteoforms, and Mass Spectrometry\u2013Based Assays for Diabetes Clinical Research, J. Clin. Endocrinol. Metab. 110 (2025) 1514\u20131523. doi:https:\/\/doi.org\/10.1210\/clinem\/dgaf159.","DOI":"10.1210\/clinem\/dgaf159"},{"key":"10.1016\/j.cca.2026.122900_bb0340","doi-asserted-by":"crossref","DOI":"10.1002\/sscp.70073","article-title":"A review on applications of liquid chromatography coupled with mass spectrometry in impurity profiling of drug substances and drug products","volume":"8","author":"Rambhad","year":"2025","journal-title":"Sep. Sci. Plus"},{"key":"10.1016\/j.cca.2026.122900_bb0410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/0471250953.bi1411s37","article-title":"LC-MS data processing with MAVEN: a metabolomic analysis and visualization engine","volume":"37","author":"Clasquin","year":"2012","journal-title":"Curr. Protoc. Bioinformatics"},{"key":"10.1016\/j.cca.2026.122900_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2024.116302","article-title":"Impact of three different peak picking software tools on the quality of untargeted metabolomics data","volume":"248","author":"Wartmann","year":"2024","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.cca.2026.122900_bb0420","article-title":"Pretreating and normalizing metabolomics data for statistical analysis","volume":"11","author":"Sun","year":"2024","journal-title":"Genes Dis."},{"key":"10.1016\/j.cca.2026.122900_bb0425","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1093\/bioinformatics\/btac355","article-title":"MAFFIN: metabolomics sample normalization using maximal density fold change with high-quality metabolic features and corrected signal intensities","volume":"38","author":"Yu","year":"2022","journal-title":"Bioinformatics"},{"key":"10.1016\/j.cca.2026.122900_bb0430","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s11306-025-02297-1","article-title":"Evaluation of normalization strategies for mass spectrometry-based multi-omics datasets","volume":"21","author":"Tseng","year":"2025","journal-title":"Metabolomics"},{"key":"10.1016\/j.cca.2026.122900_bb0435","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.3390\/molecules30122624","article-title":"Integrating NMR and MS for improved metabolomic analysis: from methodologies to applications","volume":"30","author":"de Moura","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.cca.2026.122900_bb0440","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.752250","article-title":"Quantitative analysis and visualization of the interaction between intestinal microbiota and type 1 diabetes in children based on multi-databases","volume":"9","author":"Zhao","year":"2021","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.cca.2026.122900_bb0445","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.70179","article-title":"Statistical misinterpretation of nonsignificant results in diabetes randomised clinical trials","volume":"42","author":"Sharifan","year":"2026","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.cca.2026.122900_bb0450","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3390\/metabo12040357","article-title":"Guide to metabolomics analysis: a bioinformatics workflow","volume":"12","author":"Chen","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.cca.2026.122900_bb0455","doi-asserted-by":"crossref","first-page":"1037289","DOI":"10.3389\/fendo.2022.1037289","article-title":"Untargeted metabolomics reveals gender- and age- independent metabolic changes of type 1 diabetes in Chinese children","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.cca.2026.122900_bb0460","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1111\/dom.15593","article-title":"Identification of diagnostic biomarkers used in the diagnosis of cardiovascular diseases and diabetes mellitus: A systematic review of quantitative studies, Diabetes","volume":"26","author":"Wilson","year":"2024","journal-title":"Obes. Metab."},{"key":"10.1016\/j.cca.2026.122900_bb0465","doi-asserted-by":"crossref","first-page":"1518043","DOI":"10.3389\/fendo.2025.1518043","article-title":"Metabolomics profiling identifies diagnostic metabolic signatures for pregnancy loss: a cross-sectional study from northwestern China","volume":"16","author":"Ding","year":"2025","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.cca.2026.122900_bb0470","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.aca.2019.11.006","article-title":"Bayesian multiple hypotheses testing in compositional analysis of untargeted metabolomic data","volume":"1097","author":"de Sousa","year":"2020","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.cca.2026.122900_bb0475","doi-asserted-by":"crossref","first-page":"984","DOI":"10.3390\/metabo13090984","article-title":"Bayesian statistics improves biological interpretability of metabolomics data from human cohorts","volume":"13","author":"Brydges","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.cca.2026.122900_bb0480","doi-asserted-by":"crossref","first-page":"31336","DOI":"10.1038\/s41598-024-82718-8","article-title":"Bayesian semiparametric inference in longitudinal metabolomics data","volume":"14","author":"Sarkar","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2026.122900_bb0485","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.neuropharm.2015.11.015","article-title":"Tryptophan availability for kynurenine pathway metabolism across the life span: Control mechanisms and focus on aging, exercise, diet and nutritional supplements","volume":"112","author":"Badawy","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.cca.2026.122900_bb0490","first-page":"854","article-title":"Evidence of a plateau in the incidence of type 1 diabetes in children 0\u20134 years of age from a regional pediatric diabetes center; Auckland, New Zealand: 1977\u20132019, Pediatr","volume":"22","author":"Flint","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.cca.2026.122900_bb0495","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3390\/jcm12020556","article-title":"The footprint of type 1 diabetes on red blood cells: a metabolomic and lipidomic study","volume":"12","author":"Herance","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.cca.2026.122900_bb0500","doi-asserted-by":"crossref","first-page":"1015557","DOI":"10.3389\/fendo.2022.1015557","article-title":"Multiomics signatures of type 1 diabetes with and without albuminuria","volume":"13","author":"Clos-Garcia","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.cca.2026.122900_bb0505","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jare.2023.11.025","article-title":"Machine learning approach reveals microbiome, metabolome, and lipidome profiles in type 1 diabetes","volume":"64","author":"Tan","year":"2024","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.cca.2026.122900_bb0510","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13098-017-0246-9","article-title":"Metabolic profiling of type 1 diabetes mellitus in children and adolescents: a case\u2013control study","volume":"9","author":"Bervoets","year":"2017","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.cca.2026.122900_bb0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109729","article-title":"Elevated glucose metabolism driving pro-inflammatory response in B cells contributes to the progression of type 1 diabetes","volume":"255","author":"Li","year":"2023","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.cca.2026.122900_bb0520","doi-asserted-by":"crossref","first-page":"734","DOI":"10.3390\/metabo15110734","article-title":"Dynamics of urine metabolomics and tubular inflammatory cytokines in type 1 diabetes across disease durations","volume":"15","author":"Yu","year":"2025","journal-title":"Metabolites"},{"key":"10.1016\/j.cca.2026.122900_bb0525","doi-asserted-by":"crossref","first-page":"10788","DOI":"10.3390\/ijms262110788","article-title":"Unraveling type 1 diabetes: integrating microbiome, metabolomics, and immunomodulation for next-generation therapies","volume":"26","author":"de Groen","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2026.122900_bb0530","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.2337\/db20-0104","article-title":"Circulating metabolites and lipids are associated to diabetic retinopathy in individuals with type 1 diabetes","volume":"69","author":"Curovic","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.cca.2026.122900_bb0535","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2337\/db19-0756","article-title":"Longitudinal metabolome-wide signals prior to the appearance of a first islet autoantibody in children participating in the TEDDY study","volume":"69","author":"Li","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.cca.2026.122900_bb0540","doi-asserted-by":"crossref","unstructured":"M. Pflueger, T. Sepp\u00e4nen-Laakso, T. Suortti, T. Hy\u00f6tyl\u00e4inen, P. Achenbach, E. Bonifacio, et al., Age- and Islet Autoimmunity\u2013Associated Differences in Amino Acid and Lipid Metabolites in Children at Risk for Type 1 Diabetes, Diabetes 60 (2011) 2740\u20132747. doi:https:\/\/doi.org\/10.2337\/db10-1652.","DOI":"10.2337\/db10-1652"},{"key":"10.1016\/j.cca.2026.122900_bb0545","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/biom9010033","article-title":"Cord-blood lipidome in progression to islet autoimmunity and type 1 diabetes","volume":"9","author":"Lamichhane","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.cca.2026.122900_bb0550","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.2337\/db13-0215","article-title":"Decreased cord-blood phospholipids in young age\u2013at\u2013onset type 1 diabetes","volume":"62","author":"La Torre","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.cca.2026.122900_bb0555","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1084\/jem.20081800","article-title":"Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes","volume":"205","author":"Ore\u0161i\u010d","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cca.2026.122900_bb0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105807","article-title":"Metabolome-wide Mendelian randomisation reveals causal links between circulating metabolites and type 1 diabetes","volume":"117","author":"Jumentier","year":"2025","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cca.2026.122900_bb0565","article-title":"Causal risk factors for type 1 diabetes in Mendelian randomization studies: a systematic review and meta-analysis","author":"Li","year":"2026","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.cca.2026.122900_bb0570","doi-asserted-by":"crossref","first-page":"6356","DOI":"10.1038\/s41467-022-33656-4","article-title":"Functional and metabolic alterations of gut microbiota in children with new-onset type 1 diabetes","volume":"13","author":"Yuan","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cca.2026.122900_bb0575","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/j.csbj.2022.05.015","article-title":"Statistical methods for Mendelian randomization in genome-wide association studies: a review","volume":"20","author":"Boehm","year":"2022","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.cca.2026.122900_bb0580","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/19768354.2023.2234986","article-title":"Glucose metabolic reprogramming in autoimmune diseases","volume":"27","author":"Jeong","year":"2023","journal-title":"Animal Cells Syst. (Seoul)."},{"key":"10.1016\/j.cca.2026.122900_bb0585","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13073-024-01300-z","article-title":"Systematic immune cell dysregulation and molecular subtypes revealed by single-cell RNA-seq of subjects with type 1 diabetes","volume":"16","author":"Honardoost","year":"2024","journal-title":"Genome Med."},{"key":"10.1016\/j.cca.2026.122900_bb0590","article-title":"The early detection of type 1 diabetes mellitus and latent autoimmune diabetes in adults (LADA) through rapid test reverse-flow immunochromatography for glutamic acid decarboxylase 65 kDa (GAD65)","volume":"8","author":"Aulanni\u2019am","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.cca.2026.122900_bb0595","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13098-024-01296-x","article-title":"Associations between type 1 diabetes and pulmonary tuberculosis: a bidirectional Mendelian randomization study","volume":"16","author":"Jiang","year":"2024","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.cca.2026.122900_bb0600","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s00125-019-05028-z","article-title":"Plasma ascorbic acid and the risk of islet autoimmunity and type 1 diabetes: the TEDDY study","volume":"63","author":"Mattila","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.cca.2026.122900_bb0605","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1447.062","article-title":"The Environmental Determinants of Diabetes in the Young (TEDDY) study","volume":"1150","author":"Teddy Study Group","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.cca.2026.122900_bb0610","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1399-5448.2007.00269.x","article-title":"The Environmental Determinants of Diabetes in the Young (TEDDY) study: study design","volume":"8","author":"TEDDY Study Group","year":"2007","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.cca.2026.122900_bb0615","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/dmrr.2510","article-title":"Biomarker discovery study design for type 1 diabetes in The Environmental Determinants of Diabetes in the Young (TEDDY) study","volume":"30","author":"Lee","year":"2014","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.cca.2026.122900_bb0620","doi-asserted-by":"crossref","first-page":"4516","DOI":"10.1038\/s41598-022-08058-7","article-title":"Telomere length is not a main factor for the development of islet autoimmunity and type 1 diabetes in the TEDDY study","volume":"12","author":"T\u00f6rn","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2026.122900_bb0625","article-title":"Environmental determinants and triggers of type 1 diabetes incidence among children and adolescents in europe: a narrative review","volume":"17","author":"Tiberi","year":"2026","journal-title":"Glob. Pediatr."},{"key":"10.1016\/j.cca.2026.122900_bb0630","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00125-025-06573-6","article-title":"Islet autoimmunity and progression to type 1 diabetes in the Finnish DIPP study: comparison between genetically susceptible children with and without an affected first-degree relative","volume":"69","author":"Kuusela","year":"2026","journal-title":"Diabetologia"},{"key":"10.1016\/j.cca.2026.122900_bb0635","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00125-025-06635-9","article-title":"Dietary intake of vitamins A, B, C, D and E and risk of islet autoimmunity and type 1 diabetes in genetically at-risk children: a prospective study from the DIPP birth cohort","volume":"69","author":"Mattila","year":"2026","journal-title":"Diabetologia"},{"key":"10.1016\/j.cca.2026.122900_bb0640","first-page":"847","article-title":"Dietary fatty acid intake in childhood and the risk of islet autoimmunity and type 1 diabetes: the DIPP birth cohort study","volume":"62","author":"Hakola","year":"2023","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.cca.2026.122900_bb0645","doi-asserted-by":"crossref","first-page":"10635","DOI":"10.1038\/s41598-018-28907-8","article-title":"Dynamics of plasma lipidome in progression to islet autoimmunity and type 1 diabetes\u2013type 1 diabetes prediction and prevention study (DIPP)","volume":"8","author":"Lamichhane","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2026.122900_bb0650","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.70196","article-title":"Retinol, carotenoid, and tocopherol intake and status, and the risk of islet autoimmunity and type 1 diabetes: the environmental determinants of diabetes in the young study","volume":"42","author":"Hakola","year":"2026","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.cca.2026.122900_bb0655","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2024-004130","article-title":"Environmental Determinants of Islet Autoimmunity (ENDIA) longitudinal prospective pregnancy to childhood cohort study of Australian children at risk of type 1 diabetes: parental demographics and birth information","volume":"12","author":"Thomson","year":"2024","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"10.1016\/j.cca.2026.122900_bb0660","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00125-025-06591-4","article-title":"Evolution of islet autoantibodies in the Environmental Determinants of Islet Autoimmunity (ENDIA) prospective cohort","volume":"69","author":"Couper","year":"2026","journal-title":"Diabetologia"},{"key":"10.1016\/j.cca.2026.122900_bb0665","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11892-018-1113-2","article-title":"The Environmental Determinants of Diabetes in the Young (TEDDY) study: 2018 update","volume":"18","author":"Rewers","year":"2018","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.cca.2026.122900_bb0670","doi-asserted-by":"crossref","first-page":"6167","DOI":"10.1111\/dom.70001","article-title":"Metabolomic risk predictors of diabetic foot complications: A longitudinal observational study in type 1 diabetes, Diabetes","volume":"27","author":"Andersen","year":"2025","journal-title":"Obes. Metab."},{"key":"10.1016\/j.cca.2026.122900_bb0675","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s00198-023-06734-6","article-title":"Causal relationship between Type 1 diabetes and osteoporosis and fracture occurrence: a two-sample Mendelian randomization analysis","volume":"34","author":"Tang","year":"2023","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.cca.2026.122900_bb0680","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12933-023-01974-6","article-title":"Causal associations between type 1 diabetes mellitus and cardiovascular diseases: a Mendelian randomization study","volume":"22","author":"Liu","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.cca.2026.122900_bb0685","article-title":"Associations between type 1 diabetes and autoimmune skin diseases: Mendelian randomization analysis","volume":"10","author":"Liu","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.cca.2026.122900_bb0690","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s43586-021-00092-5","article-title":"Mendelian randomization","volume":"2","author":"Sanderson","year":"2022","journal-title":"Nat. Rev. Methods Primers"},{"key":"10.1016\/j.cca.2026.122900_bb0695","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.70168","article-title":"Gene-Lifestyle Interplay in Type 1 Diabetes: Joint Effects and Interactions From Cross-Sectional and Longitudinal Cohort Analyses","volume":"42","author":"Lai","year":"2026","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.cca.2026.122900_bb0700","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12933-023-02117-7","article-title":"Type 1 diabetes, its complications, and non-ischemic cardiomyopathy: a Mendelian randomization study of European ancestry","volume":"23","author":"Zhao","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.cca.2026.122900_bb0705","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s40200-026-01926-3","article-title":"Causal relationship between immune cells, inflammatory mediation, and type 1 diabetes: a Mendelian randomization study","volume":"25","author":"Lv","year":"2026","journal-title":"J. Diabetes Metab. Disord."},{"key":"10.1016\/j.cca.2026.122900_bb0710","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11892-023-01509-z","article-title":"Using mixed methods research in children with type 1 diabetes: a methodological review","volume":"23","author":"Davis","year":"2023","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.cca.2026.122900_bb0715","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.3390\/ijms26093935","article-title":"Harnessing machine learning, a subset of artificial intelligence, for early detection and diagnosis of type 1 diabetes: A systematic review","volume":"26","author":"Mittal","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2026.122900_bb0720","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e41199","article-title":"Evaluation of machine learning-based regression techniques for prediction of diabetes levels fluctuations","volume":"11","author":"Alkalifah","year":"2025","journal-title":"Heliyon"},{"key":"10.1016\/j.cca.2026.122900_bb0725","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/1753-0407.13093","article-title":"Prediction of the development of islet autoantibodies through integration of environmental, genetic, and metabolic markers","volume":"13","author":"Webb-Robertson","year":"2021","journal-title":"J. Diabetes"},{"key":"10.1016\/j.cca.2026.122900_bb0730","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1038\/s41467-022-28909-1","article-title":"Progression of type 1 diabetes from latency to symptomatic disease is predicted by distinct autoimmune trajectories","volume":"13","author":"Kwon","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cca.2026.122900_bb0735","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S2213-8587(24)00279-1","article-title":"Treatment regimens and glycaemic outcomes in more than 100000 children with type 1 diabetes (2013-22): a longitudinal analysis of data from paediatric diabetes registries","volume":"13","author":"Zimmermann","year":"2025","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.cca.2026.122900_bb0740","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/s11892-014-0520-2","article-title":"Young children with type 1 diabetes: challenges, research, and future directions","volume":"14","author":"Streisand","year":"2014","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.cca.2026.122900_bb0745","doi-asserted-by":"crossref","first-page":"12709","DOI":"10.1038\/s41598-020-69350-y","article-title":"High fractional excretion of glycation adducts is associated with subsequent early decline in renal function in type 1 diabetes","volume":"10","author":"Perkins","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2026.122900_bb0750","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.831793","article-title":"Cardiovascular autonomic neuropathy in type 1 diabetes is associated with disturbances in TCA, lipid, and glucose metabolism","volume":"13","author":"Hansen","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.cca.2026.122900_bb0755","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1186\/s12933-024-02512-8","article-title":"Urinary metabolomics provide insights into coronary artery disease in individuals with type 1 diabetes","volume":"23","author":"Antikainen","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.cca.2026.122900_bb0760","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41366-023-01429-8","article-title":"The emergence of obesity in type 1 diabetes","volume":"48","author":"Kueh","year":"2024","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.cca.2026.122900_bb0765","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1021\/acs.jproteome.3c00717","article-title":"Exploring the Interactions between Obesity and Diabetes: Implications for Understanding Metabolic Dysregulation in a Saudi Arabian Adult Population","volume":"23","author":"Ahmad","year":"2024","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.cca.2026.122900_bb0770","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e32824","article-title":"Microalbuminuria and lipid variations in adolescents diagnosed with type 1 diabetes","volume":"10","author":"Mohammedsaeed","year":"2024","journal-title":"Heliyon"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126020826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126020826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T06:23:34Z","timestamp":1792391014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898126020826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,3]]},"references-count":154,"alternative-id":["S0009898126020826"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2026.122900","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2027,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type 1 diabetes metabolomics and multi-omics: Current applications, limitations, and future directions - A narrative review","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2026.122900","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"122900"}}